Directors Dealings

The Board of Sutherland Health Group announces that the directors purchased shares in the market.

                                                                                                                                                 30 April 2010

                                                        SUTHERLAND HEALTH GROUP PLC
                                            (“Sutherland Health Group” or “the Company”)
                                                                PLUS Symbol: SHGP


The Board of Sutherland Health Group, a national supplier of patient hygiene, and sexual health products to customers including the NHS, announces that the following Directors purchased shares in the market.

Chairman John French purchased 78,000 shares at 2.5p on 28 April 2010 and now has an interest in 1,033,225 Ordinary Shares representing 1.88% of the Company.

Chief Executive George Sutherland purchased 49,000 shares at 2.5p and a further 26,000 shares at 2.73p on 28 April 2010 and now has an interest in 28,776,220 Ordinary Shares. George is also interested, under connected person disclosure in 45,000 ordinary shares held by Sheena Sukumaran, his wife, a fellow director of the Company. His total shareholding is 28,821,220 ordinary shares representing 52.39% of the Company.

The total Directors' shareholding is 30,096,945 Ordinary Shares representing 54.71% of the issued ordinary share capital.

The total Ordinary shares in issue are 55,008,060.


The Directors of the Issuer accept responsibility for this announcement.


John French, Chairman
Sutherland Health Group plc
T: 07836 722 482

Bridge Hall
Alex Benger
T: 020 7337 9705

Bishopsgate Communications Ltd.
Maxine Barnes
T: 020 7562 3367 

Notes to Editors:

Sutherland Health Group Plc is a national supplier of patient hygiene, sexual health and diagnostic products to the UK National Health Service (NHS) and other UK customers. Its aim is to supply innovative solutions to current health issues by studying current trends and working alongside leading professionals who also work within the health sector.

The company is committed to developing and marketing high quality brands and products that will benefit health professionals and consumers alike in many areas of health. The Group has established its own brands Condomania® Condoms, Sutherland® Lubricating Jelly and Vision® pregnancy diagnostics that have already become established within the NHS business.

The Company has also developed the Sutherland® patient hygiene range which is now on contract with NHS England and NHS Northern Ireland that can reduce the risk to patients of cross infection.

The Group is ISO and MHRA registered, and at present principally operates within the United Kingdom.

For further information on the Company visit

Latest news RSS


Sutherland at Procurex Wales 2017

Sutherland at Procurex Wales 2017


Final Results 30th September 2016

Sutherland Health Group Final Results September 2016


Sutherland Attending European Midwives Conference

Sutherland Attending EMA Conference

Sign up


For further information, please read our Privacy Policy.